Abingdon Health

Our mission: To improve life through innovation in rapid testing. We do this by combining industry expertise with rapid test technology innovation and best-in-class automation.Abingdon Health is a technology-enabled lateral flow diagnostics company providing leading-edge rapid testing solutions to a multi-industry, global client base. Abingdon Health provides lateral flow assay development and smartphone reader solutions alongside Europe’s largest rapid test manufacturing capacity.A multi-disciplinary team forms the foundations of our services and a partnership-led approach alongside a focus on operational excellence produces reliable products irrespective of their complexity. Established supply chain and manufacturing processes are tailored to assay specifications and market demand for continuity of supply.Abingdon Health is the lead manufacturer of AbC-19, a rapid test for the detection of IgG neutralising antibodies to SARS-CoV-2 (COVID-19). The test was developed by Abingdon Health on behalf of the UK Rapid Test Consortium (UK-RTC).Abingdon Health is headquartered in York, UK, with additional sites across the UK in Doncaster and Birmingham.The health and wellbeing of people is at the heart of everything Abingdon Health does.- Delivering rapid diagnostic tests and data solutions streamlines testing and speeds up outcome management and treatment decision-making.- Employee development and empowerment supports the futures of our team members and their families.- Working with charity partners and responsibly managing environmental impact helps to give back to the communities we work and live in.- Long-term partnerships across multiple sectors positively contributes to the One Health movement.We have also developed, manufactured and commercialised our own rapid tests: Seralite® FLC a quantitative aid in the diagnosis and management of multiple myeloma (blood cancer), NALFIA tests and Pocket Diagnostic.